CTRI/2022/03/040725已完成2 期
Clinical Study to Evaluate the Efficacy and Safety of LION�S MANE CAPSULE (HERICIUM ERINACEUS) as Nutritional Supplement in Patients with Co morbidities.
DXN Manufacturing India Pvt Ltd0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Participants aged 18-60 years (both sex).
- •2.Participants who are determined to be at risk for malnutrition based on the Malnutrition Screening Tool for adults and presenting with any one of the co morbidities like Systemic hypertension or Diabetes Mellitus or
- •Hyperlipidemia.
排除标准
- •1. Participants presenting with fever and acute infections, will be excluded.
- •2. History of heart, liver or kidney failure.
- •3. Allergy or intolerance to the individual constituents in test product.
- •4. Patients with history of thyroid abnormalities.
- •5. Patients with history of any malignancy
- •6. History of any Neurodegenerative disease
- •7. Organ transplantation
- •8. Allergy to fungi
- •9. Subjects who are pregnant and lactating mothers, or with any serious
- •disease condition limiting full adhesion to the protocol.
- •10. Participation in an investigational drug trial in the 30 days prior to the
- •screening visit.
研究者
相似试验
进行中（未招募）
不适用
Clinical Study to Evaluate the Efficacy and Safety of the Combination Therapy Candesartan Cilexetil 32 mg plus Hydrochlorothiazide 25 mg in Patients with Severe HypertensioSubjects with severe essential hypertension (SBP between 150 mmHg and 200 mmHg AND DBP between 110 mmHg and 120 mmHg) who did not receive any antihypertensive treatment before will be included in the studyMedDRA version: 9.1Level: LLTClassification code 10015488Term: Essential hypertensionEUCTR2009-011776-30-DETakeda Pharma GmbH100
已完成
2 期
TO Find the Effect of Codyceps Tablet as Nutritional SupplementCTRI/2022/03/040784DXN Manufacturing India Pvt Ltd24
已完成
2 期
To Find the Effect of LION�S MANE TABLET as a Nutritional SupplementCTRI/2022/03/040733DXN Manufacturing India Pvt Ltd24
招募中
1 期
Evaluate The Efficacy And Safety Of HMTG-122106 In ChildreCTRI/2023/07/054858Himalaya Wellness Company
尚未招募
3 期
Result of Psorlyn tablet and Psorlyn oil in Psoriasis(skin disease).CTRI/2021/04/033243DrVasishths Ayuremedies